The purpose of this study is to find out more about an investigational drug. This study is designed to use Fluorodeoxyglucose (FDG) positron emission tomography (PET) / computed tomography (CT) imaging to test the effect of an investigational drug for atherosclerotic inflammation. Participation could be up to five months and could involve up to eight study visits. The visits are in person.
Site: Baylor College of Medicine
Study Doctor: Christie Ballantyne, M.D.
Study Contact: Sharon Goss (713) 798-8800 or email@example.com